Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Madersbacher

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
European Urology|August 8, 2018
Re: Comparison of Prostatic Artery Embolization (PAE) Versus Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia: Randomised, Open Label, Non-inferiority TrialStephan Madersbacher
BJU International|July 16, 2016
Responsiveness to medical benign prostatic hyperplasia therapy: is there a genetic factor?Stephan Madersbacher
European Urology|April 14, 2018
Re: WATER: A Double-blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaStephan Madersbacher
European Urology|January 18, 2006
Stents for prostatic diseases: any progress after 25 years?Stephan Madersbacher
European Urology|August 20, 2009
Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndromeStephan Madersbacher
European Urology|March 21, 2007
Re: Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled studyStephan Madersbacher
European Urology|September 17, 2010
Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al. REDUCE Study Group. N Engl J Med 2010;362:1192-202Stephan Madersbacher
European Urology|February 4, 2017
Re: Functional Outcomes After Transurethral Resection of the Prostate in Nursing Home ResidentsStephan Madersbacher
European Urology|May 20, 2008
Editorial comment on: GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 proceduresStephan Madersbacher
Urology|September 3, 2011
Editorial commentStephan Madersbacher
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
European Urology|August 8, 2018
Re: Comparison of Prostatic Artery Embolization (PAE) Versus Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia: Randomised, Open Label, Non-inferiority TrialStephan Madersbacher
BJU International|July 16, 2016
Responsiveness to medical benign prostatic hyperplasia therapy: is there a genetic factor?Stephan Madersbacher
European Urology|April 14, 2018
Re: WATER: A Double-blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaStephan Madersbacher
European Urology|January 18, 2006
Stents for prostatic diseases: any progress after 25 years?Stephan Madersbacher
European Urology|August 20, 2009
Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndromeStephan Madersbacher
European Urology|March 21, 2007
Re: Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled studyStephan Madersbacher
European Urology|September 17, 2010
Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al. REDUCE Study Group. N Engl J Med 2010;362:1192-202Stephan Madersbacher
European Urology|February 4, 2017
Re: Functional Outcomes After Transurethral Resection of the Prostate in Nursing Home ResidentsStephan Madersbacher
European Urology|May 20, 2008
Editorial comment on: GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 proceduresStephan Madersbacher
Urology|September 3, 2011
Editorial commentStephan Madersbacher
Pageof 19